These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1679047)
1. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course. McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047 [TBL] [Abstract][Full Text] [Related]
2. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure. Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946 [TBL] [Abstract][Full Text] [Related]
3. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group. Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945 [TBL] [Abstract][Full Text] [Related]
4. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects. Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200 [TBL] [Abstract][Full Text] [Related]
5. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol. Erlemeier HH; Kupper W; Bleifeld W Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349 [TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine changes post myocardial infarction: effects of xamoterol. McMurray JJ; Lang CC; MacLean D; McDevitt DG; Struthers AD Am Heart J; 1990 Jul; 120(1):56-62. PubMed ID: 1972861 [TBL] [Abstract][Full Text] [Related]
7. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure. Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587 [TBL] [Abstract][Full Text] [Related]
8. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure]. Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820 [No Abstract] [Full Text] [Related]
9. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial. de Feyter PJ; Serruys PW; Suryapranata H Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of digoxin and xamoterol on arrhythmias in patients with mild to moderate heart failure. Klein W; Eber B; Rotman B Angiology; 1992 Apr; 43(4):281-6. PubMed ID: 1348403 [TBL] [Abstract][Full Text] [Related]
11. Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris. Barrios L; Geboers J; Piessens JH; de Geest H Eur J Clin Pharmacol; 1986; 29(6):667-71. PubMed ID: 2872055 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation. Lundström T; Moor E; Rydén L Am Heart J; 1992 Oct; 124(4):917-23. PubMed ID: 1356311 [TBL] [Abstract][Full Text] [Related]
13. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest. Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751 [TBL] [Abstract][Full Text] [Related]
14. Sympathetic modulation in practice: the German clinical experience. Kupper W; Erlemeier HH; Bleifeld W Eur Heart J; 1990 Apr; 11 Suppl A():19-25. PubMed ID: 1971586 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure. Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867 [TBL] [Abstract][Full Text] [Related]
16. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status. Heng MK Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783 [TBL] [Abstract][Full Text] [Related]
17. Xamoterol in hypertrophic cardiomyopathy: effects on diastolic function and heart rate. Gilligan DM; Stewart R; Chan WL; Oakley CM Int J Cardiol; 1992 Jun; 35(3):377-86. PubMed ID: 1351887 [TBL] [Abstract][Full Text] [Related]
18. Exercise capacity, arrhythmias, humoral and chemical parameters during long-term therapy with xamoterol. Erlemeier HH; Kupper W; Bleifeld W Int J Cardiol; 1990 Aug; 28(2):197-208. PubMed ID: 1697569 [TBL] [Abstract][Full Text] [Related]
19. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)]. Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823 [TBL] [Abstract][Full Text] [Related]
20. Acute haemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol at rest and during supine exercise in patients with left ventricular dysfunction due to ischaemic heart disease: a double-blind randomized trial. de Feyter PJ; Serruys PW Eur Heart J; 1990 Apr; 11 Suppl A():48-9. PubMed ID: 1971590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]